Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.

BACKGROUND: Clozapine (clozaril, Mylan Products Ltd) is a first-choice treatment for people with schizophrenia who have a poor response to standard antipsychotic medication. However, a significant number of patients who trial clozapine have an inadequate response and experience persistent symptoms,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Health Technol Assess
Autores principales: Morrison, Anthony P, Pyle, Melissa, Gumley, Andrew, Schwannauer, Matthias, Turkington, Douglas, MacLennan, Graeme, Norrie, John, Hudson, Jemma, Bowe, Samantha, French, Paul, Hutton, Paul, Byrne, Rory, Syrett, Suzy, Dudley, Robert, McLeod, Hamish J, Griffiths, Helen, Barnes, Thomas Re, Davies, Linda, Shields, Gemma, Buck, Deborah, Tully, Sarah, Kingdon, David
Formato: Artigo
Lenguaje:Inglês
Publicado: NIHR Journals Library 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409493/
https://ncbi.nlm.nih.gov/pubmed/30806619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta23070
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares